Original Research
Accepted on 28 Mar 2024
RAD51 as an immunohistochemistry-based marker of poly(ADPribose) polymerase inhibitor resistance in ovarian cancer
in Gynecological Oncology
Original Research
Accepted on 28 Mar 2024
in Gynecological Oncology
Editorial
Accepted on 28 Mar 2024
in Molecular and Cellular Oncology
Editorial
Accepted on 28 Mar 2024
in Molecular and Cellular Oncology
Original Research
Accepted on 28 Mar 2024
in Surgical Oncology
Original Research
Accepted on 28 Mar 2024
in Breast Cancer
Review
Accepted on 28 Mar 2024
in Breast Cancer
Original Research
Accepted on 28 Mar 2024
in Genitourinary Oncology
Original Research
Accepted on 28 Mar 2024
in Hematologic Malignancies
Review
Accepted on 28 Mar 2024
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 28 Mar 2024
in Cancer Epidemiology and Prevention
Editorial
Accepted on 28 Mar 2024
in Pharmacology of Anti-Cancer Drugs
Review
Accepted on 28 Mar 2024
in Hematologic Malignancies
Review
Accepted on 28 Mar 2024
in Surgical Oncology
Brief Research Report
Accepted on 28 Mar 2024
in Cancer Molecular Targets and Therapeutics
Original Research
Accepted on 28 Mar 2024
in Pediatric Oncology
Case Report
Published on 28 Mar 2024
in Neuro-Oncology and Neurosurgical Oncology